​

Funding Round

Series A - ReviR Therapeutics

Series A - ReviR Therapeutics

Investment Firm

Overview

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Announced Date

Jul 26, 2024

Closed on Date

Jul 26, 2024

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Lapam Capital

Lapam Capital

Lapam Capital is a early_stage_venture firm.

Participant Investors

4

Investor Name
Participant InvestorLapam Capital
Participant InvestorYael Capital Management Limited
Participant Investor5Y Capital
Participant InvestorCDH Investments

Round Details and Background

ReviR Therapeutics raised $30000000 on 2024-07-26 in Series A

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 17, 2022
Seed Round - ReviR Therapeutics
5-20.0M
Jun 19, 2024
Grant - ReviR Therapeutics
1-undefined
Jul 26, 2024
Series A - ReviR Therapeutics
6-30.0M

Recent Activity

There is no recent news or activity for this profile.